Last edition
News about
Canon Medical Systems and RGCIRC Partner for Advanced Cancer Diagnostics Research
The Rajiv Gandhi Cancer Institute and Research Centre has signed a Memorandum of Understanding (MoU) with Canon Medical Systems to use its 640-slice CT system, Aquilion ONE/ INSIGHT Edition for research on advanced cancer diagnostics.
Evernorth Invests USD 3.5 Billion in Shields to Deepen Specialty Pharmacy Reach
Evernorth, a subsidiary of Cigna Group, is investing USD 3.5 billion in Shields Health Solutions, a company focused on specialty pharmacy management. This investment arrives as Shields establishes itself as a standalone entity following its acquisition by private equity firm Sycamore Partners after the Walgreens demerger.
India Emerges as Global Manufacturing Powerhouse in Life Sciences: EY Report
India is fast becoming a global hub for life sciences Global Capability Centres (GCCs), according to the latest EY report. Nearly half of the world's top 50 life sciences firms now operate GCCs in the country, amounting to around 100 centres, with plans to scale this number to 160 over the next five years.
LOTTE BIOLOGICS Enters Contract Manufacturing Partnership with US Biopharma
South Korea’s LOTTE BIOLOGICS has signed a late-stage to commercial contract manufacturing agreement with a US-based global biopharmaceutical company.
Servier and IDEAYA Biosciences have entered into an exclusive license agreement to globally develop and commercialise darovasertib, a potential first-in-class therapy for uveal melanoma, with Servier taking rights outside the US and IDEAYA retaining US rights.
SK bioscience Files IND for Global Phase 3 Trial of Two-Dose Varicella Vaccine
SK bioscience's Phase 3 clinical trial of SKYVaricella aims to evaluate the immunogenicity and safety of the 2-shot varicella vaccine in roughly 800 children aged 12 months to 12 years, with completion targeted by 2027.
Remedium Lifecare Unveils 4-Point Growth Strategy
Remedium Lifecare Ltd. has unveiled a 4-point strategic roadmap – spanning advanced manufacturing, global expansion, R&D innovation, and product diversification.
Asston Pharmaceuticals Secures International Supply Order Worth INR 2.65 Crore
Asston Pharmaceuticals has received an order from a leading international pharmaceutical company to supply a range of pharma products worth INR 2.65 crore
Four Drugs in Race for First Bispecific ADC Approval: GlobalData
With 21 global approvals, ADCs generated USD 13.6 billion in 2024. BsADCs represent further opportunities in this field, by leveraging bi-specific antibodies that simultaneously bind two distinct targets.
Next-Gen PAS-X MES 3.4 Enhances Efficiency and Compliance in Life Sciences Manufacturing
Körber has launched the latest version of its PAS-X Manufacturing Execution System (MES), introducing PAS-X MES 3.4, a next-generation solution designed to modernize pharmaceutical manufacturing.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy